Evidence map›Paper›PMID 37535101›Full record

ArticleCell and tissue research2023

Discovery of a novel marker for human granulocytes and tissue macrophages: RTL1 revisited.

Sahar Mortezagholi, Ahmad-Reza Mahmoudi, Sorour Shojaeian, Sedigheh Vafaei, Haleh Soltanghoraei, Ali-Ahmad Bayat, Fazel Shokri, Roya Ghods, Amir-Hassan Zarnani

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Sahar Mortezagholi *Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ahmad-Reza Mahmoudi *Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
Sorour ShojaeianDepartment of Biochemistry, Alborz University of Medical Sciences, Karaj, Iran.
Sedigheh VafaeiReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Haleh SoltanghoraeiReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Ali-Ahmad BayatReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
Fazel ShokriDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Roya GhodsOncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. rghods77@yahoo.com.
Amir-Hassan ZarnaniReproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. zarnania@tums.ac.ir.ORCID http://orcid.org/0000-0003-4503-299X
Academic Center for Education, Culture and Research · IRIran University of Medical Sciences · IRJahrom University of Medical Sciences · IRRoyan Institute · IRShahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

Iran University of Medical Sciences 95-03-138-29530National Institute for Medical Research Development 971138
6 · The paper itself

Abstract

Here, retrotransposon-like 1 (RTL1) is introduced as a marker for circulating and tissue neutrophils, tissue macrophages, and tumor-associated macrophages (TAM) and neutrophils (TAN). Anti-RTL1 polyclonal and monoclonal antibodies were produced, and their reactivity was examined by Western blotting (WB), ELISA, and immunostaining of human normal and cancer tissues. The reactivity of the anti-RTL1 antibodies with peripheral blood leukocytes and a panel of hematopoietic cell lines was examined. The generated antibodies specifically detected RTL1 in the WB of the placenta and U937 cells. The polyclonal antibody showed excellent reactivity with tissue-resident macrophages, Hofbauer cells, alveolar and splenic macrophages, Kupffer cells, and inflammatory cells in the tonsil, appendix, and gallbladder. In vitro GM-CSF-differentiated macrophages also showed a high level of intracellular RTL1 expression. TAM and TAN also showed excellent reactivity with this antibody. Almost all circulating granulocytes but not lymphocytes or monocytes expressed RTL1 at their surface. Serial sections of the appendix stained with CD15 and RTL1 and placenta stained with CD68 and RTL1 showed a considerable overlap in RTL1 expression in CD15

Indexed as

GranulocytesMacrophagesBiomarkersFemaleHumansBiomarkersGranulocyteMacrophageRTL1TAMTAN

Identifiers

PMID37535101
OpenAlexW4385514899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.